Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Accumulated Expenses: 2013-2018

Historic Accumulated Expenses for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2018 value amounting to $274,000.

  • Soleno Therapeutics' Accumulated Expenses rose 49.09% to $1.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.7 million, marking a year-over-year increase of 49.09%. This contributed to the annual value of $274,000 for FY2018, which is 71.84% down from last year.
  • According to the latest figures from FY2018, Soleno Therapeutics' Accumulated Expenses is $274,000, which was down 71.84% from $973,000 recorded in FY2017.
  • Soleno Therapeutics' Accumulated Expenses' 5-year high stood at $1.6 million during FY2015, with a 5-year trough of $201,457 in FY2014.
  • Moreover, its 3-year median value for Accumulated Expenses was $973,000 (2017), whereas its average is $765,822.
  • As far as peak fluctuations go, Soleno Therapeutics' Accumulated Expenses skyrocketed by 710.44% in 2015, and later plummeted by 71.84% in 2018.
  • Yearly analysis of 5 years shows Soleno Therapeutics' Accumulated Expenses stood at $201,457 in 2014, then skyrocketed by 710.44% to $1.6 million in 2015, then crashed by 35.66% to $1.1 million in 2016, then decreased by 7.37% to $973,000 in 2017, then plummeted by 71.84% to $274,000 in 2018.